Renal denervation: A potential new treatment modality for polycystic ovary syndrome?

Journal of Hypertension

Volumn 29, Issue 5, 2011, Pages 991-996

  Schlaich, Markus P ^a,e   Straznicky, Nora ^a   Grima, Mariee ^a   Ika Sari, Carolina ^a   Dawood, Tye ^a   Mahfoud, Felix ^b   Lambert, Elisabeth ^a   Chopra, Reena ^a   Socratous, Flora ^a   Hennebry, Sarah ^a   Eikelis, Nina ^a   Böhm, Michael ^b   Krum, Henry ^d   Lambert, Gavin ^a   Esler, Murray D ^a   Sobotka, Paul A ^c  

^a ALFRED HOSPITAL   (Australia)

^b SAARLAND UNIVERSITY   (Germany)

^c Ardian Inc   (United States)

^d MONASH UNIVERSITY   (Australia)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

insulin sensitivity; norepinephrine; renal denervation; sympathetic

Indexed keywords

ALBUMIN; AMLODIPINE PLUS VALSARTAN; CREATININE; CYSTATIN C; GLUCOSE; HYDROCHLOROTHIAZIDE PLUS IRBESARTAN; METHYLDOPA; MOXONIDINE; NORADRENALIN; PRAZOSIN; RAMIPRIL; SPIRONOLACTONE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; CATHETER ABLATION; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; KIDNEY DENERVATION; MICROALBUMINURIA; MUSCLE INNERVATION; NEUROGRAPHY; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; WEIGHT CHANGE;

EID: 79954824358     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328344db3a     Document Type: Article

References (26)

1. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in .2005. and projections to 2030. Int J Obes (Lond) 2008; 32:1431-1437.
2. Alexander CJ, Tangchitnob EP, Lepor NE. Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women. Rev Obstet Gynecol 2009; 2:232-239.
3. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8:41.
4. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007; 370:685-697. (Pubitemid 47285318)
5. Sverrisdottir YB, Mogren T, Kataoka J, Janson PO, Stener-Victorin E. Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? Am J Physiol Endocrinol Metab 2008; 294:E576-581. (Pubitemid 351355228)
6. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 2004; 43:169-175. (Pubitemid 38174169)
7. Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003; 108:560-565. (Pubitemid 36961170)
8. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 1997; 77:75-197. (Pubitemid 27069290)
9. Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 2004; 22:2363-2369. (Pubitemid 39620287)
10. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 1990; 85:1844-1852. (Pubitemid 20192958)
11. Rasio EA. Passage of glucose through the cell membrane of capillary endothelium. Am J Physiol 1975; 228:1103-1107.
12. Masuo K, Mikami H, Ogihara T, Tuck ML. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 1997; 10:77-83. (Pubitemid 27038975)
13. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373:1275-1281.
14. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009; 361:932-934.
15. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-223. (Pubitemid 9249478)
16. Lara HE, Ferruz JL, Luza S, Bustamante DA, Borges Y, Ojeda SR. Activation of ovarian sympathetic nerves in polycystic ovary syndrome. Endocrinology 1993; 133:2690-2695. (Pubitemid 24000721)
17. Haenni A, Lithell H. Moxonidine improves insulin sensitivity in insulinresistant hypertensives. J Hypertens Suppl 1999; 17:S29-35.
18. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993; 21:618-623. (Pubitemid 23120215)
19. Egan BM. Neurohumoral, hemodynamic and microvascular changes as mechanisms of insulin resistance in hypertension: a provocative but partial picture. Int J Obes 1991; 15 (Suppl 2):133-139.
20. Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension 2009; 54:1195-1201.
21. Jerums G, Panagiotopoulos S, Premaratne E, MacIsaac RJ. Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat Rev Nephrol 2009; 5:397-406.
22. Mogensen CE. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria? Diabetes 1990; 39:761-767. (Pubitemid 20211422)
23. Barria A, Leyton V, Ojeda SR, Lara HE. Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation. Endocrinology 1993; 133:2696-2703. (Pubitemid 24000722)
24. Semenova II. Adrenergic innervation of ovaries in Stein-Leventhal syndrome. Vestn Akad Med Nauk SSSR 1969; 24:58-62.
25. Nakamura Y. Treatment of polycystic ovary syndrome: an overview. Horm Res 1990; 33 (Suppl 2):31. (Pubitemid 20236434)
26. Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol 2009; 20:933-939.